{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:27:40Z","timestamp":1790954860137,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100377"],"award-info":[{"award-number":["82100377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z211100002121046"],"award-info":[{"award-number":["Z211100002121046"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10443-5","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:06:07Z","timestamp":1728367567000},"page":"55-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential of plasma biomarkers for heart failure prediction, management, and prognosis: A multiomics perspective"],"prefix":"10.1007","volume":"30","author":[{"given":"Erhou","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"18","key":"10443_CR1","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/cir.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895\u2013e1032. https:\/\/doi.org\/10.1161\/cir.0000000000001063","journal-title":"Circulation"},{"issue":"36","key":"10443_CR2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"20","key":"10443_CR3","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jacc.2023.03.402","volume":"81","author":"S Sukumar","year":"2023","unstructured":"Sukumar S, Wasfy JH, Januzzi JL et al (2023) Financial toxicity of medical management of heart failure: JACC review topic of the week. J Am Coll Cardiol 81(20):2043\u20132055. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.402","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10443_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","volume":"38","author":"M Urbich","year":"2020","unstructured":"Urbich M, Globe G, Pantiri K et al (2020) A systematic review of medical costs associated with heart failure in the USA (2014\u20132020). Pharmacoeconomics 38(11):1219\u20131236. https:\/\/doi.org\/10.1007\/s40273-020-00952-0","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10443_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10741-024-10397-8","volume":"29","author":"A Teimourizad","year":"2024","unstructured":"Teimourizad A, Jafari A, Esmaeilzadeh F (2024) Budget impact analyses for treatment of heart failure. Syst Rev Heart Fail Rev 29(4):785\u2013797. https:\/\/doi.org\/10.1007\/s10741-024-10397-8","journal-title":"Syst Rev Heart Fail Rev"},{"issue":"4","key":"10443_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.15212\/cvia.2022.0005","volume":"6","author":"Z Hao","year":"2022","unstructured":"Hao Z, Zhang Y (2022) Dapagliflozin in heart failure with reduced ejection fraction a real-world study. Cardiovasc Innov Appl 6(4):219\u2013223. https:\/\/doi.org\/10.15212\/cvia.2022.0005","journal-title":"Cardiovasc Innov Appl"},{"issue":"36","key":"10443_CR7","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/eurheartj\/ehaa270","volume":"41","author":"A Bayes-Genis","year":"2020","unstructured":"Bayes-Genis A, Liu PP, Lanfear DE et al (2020) Omics phenotyping in heart failure: the next frontier. Eur Heart J 41(36):3477\u20133484. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa270","journal-title":"Eur Heart J"},{"issue":"11","key":"10443_CR8","doi-asserted-by":"publisher","first-page":"E1317","DOI":"10.1073\/pnas.1500076112","volume":"112","author":"P Jiang","year":"2015","unstructured":"Jiang P, Chan CW, Chan KC et al (2015) Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A 112(11):E1317-1325. https:\/\/doi.org\/10.1073\/pnas.1500076112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10443_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1373\/clinchem.2011.174250","volume":"58","author":"S Quake","year":"2012","unstructured":"Quake S (2012) Sizing up cell-free DNA. Clin Chem 58(3):489\u2013490. https:\/\/doi.org\/10.1373\/clinchem.2011.174250","journal-title":"Clin Chem"},{"issue":"18","key":"10443_CR10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","volume":"379","author":"RB Corcoran","year":"2018","unstructured":"Corcoran RB, Chabner BA (2018) Application of cell-free DNA analysis to cancer treatment. N Engl J Med 379(18):1754\u20131765. https:\/\/doi.org\/10.1056\/NEJMra1706174","journal-title":"N Engl J Med"},{"issue":"12","key":"10443_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","volume":"40","author":"A Jamshidi","year":"2022","unstructured":"Jamshidi A, Liu MC, Klein EA et al (2022) Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell 40(12):1537-1549.e1512. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.022","journal-title":"Cancer Cell"},{"issue":"5","key":"10443_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK (2018) Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med 379(5):464\u2013473. https:\/\/doi.org\/10.1056\/NEJMra1705345","journal-title":"N Engl J Med"},{"key":"10443_CR13","doi-asserted-by":"publisher","unstructured":"Lo Y M D, Han D S C, Jiang P et al. (2021) Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 372(6538). https:\/\/doi.org\/10.1126\/science.aaw3616","DOI":"10.1126\/science.aaw3616"},{"issue":"6","key":"10443_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cjca.2019.10.016","volume":"36","author":"T Yokokawa","year":"2020","unstructured":"Yokokawa T, Misaka T, Kimishima Y et al (2020) Clinical significance of circulating cardiomyocyte-specific cell-free DNA in patients with heart failure: a proof-of-concept study. Can J Cardiol 36(6):931\u2013935. https:\/\/doi.org\/10.1016\/j.cjca.2019.10.016","journal-title":"Can J Cardiol"},{"issue":"9","key":"10443_CR15","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1177\/2047487320912375","volume":"28","author":"A Salzano","year":"2021","unstructured":"Salzano A, Israr MZ, Garcia DF et al (2021) Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure. Eur J Prev Cardiol 28(9):e28\u2013e31. https:\/\/doi.org\/10.1177\/2047487320912375","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10443_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/2048872618823405","volume":"9","author":"KA Krychtiuk","year":"2020","unstructured":"Krychtiuk KA, Wurm R, Ruhittel S et al (2020) Release of mitochondrial DNA is associated with mortality in severe acute heart failure. Eur Heart J Acute Cardiovasc Care 9(5):419\u2013428. https:\/\/doi.org\/10.1177\/2048872618823405","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"8","key":"10443_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1089\/dna.2022.0238","volume":"41","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, He X, Ling J et al (2022) Association between circulating cell-free DNA level at admission and the risk of heart failure incidence in acute myocardial infarction patients. DNA Cell Biol 41(8):742\u2013749. https:\/\/doi.org\/10.1089\/dna.2022.0238","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10443_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11239-010-0527-8","volume":"31","author":"A Zaravinos","year":"2011","unstructured":"Zaravinos A, Tzoras S, Apostolakis S et al (2011) Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy. J Thromb Thrombolysis 31(2):180\u2013187. https:\/\/doi.org\/10.1007\/s11239-010-0527-8","journal-title":"J Thromb Thrombolysis"},{"key":"10443_CR19","doi-asserted-by":"publisher","unstructured":"De Vlaminck I, Valantine H A, Snyder T M et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6(241):241ra277. https:\/\/doi.org\/10.1126\/scitranslmed.3007803","DOI":"10.1126\/scitranslmed.3007803"},{"issue":"9","key":"10443_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.healun.2017.05.026","volume":"36","author":"S Agbor-Enoh","year":"2017","unstructured":"Agbor-Enoh S, Tunc I, De Vlaminck I et al (2017) Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. J Heart Lung Transplant 36(9):1004\u20131012. https:\/\/doi.org\/10.1016\/j.healun.2017.05.026","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"10443_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/circulationaha.120.049098","volume":"143","author":"S Agbor-Enoh","year":"2021","unstructured":"Agbor-Enoh S, Shah P, Tunc I et al (2021) Cell-free DNA to detect heart allograft acute rejection. Circulation 143(12):1184\u20131197. https:\/\/doi.org\/10.1161\/circulationaha.120.049098","journal-title":"Circulation"},{"issue":"4","key":"10443_CR22","doi-asserted-by":"publisher","first-page":"e011160","DOI":"10.1161\/circheartfailure.123.011160","volume":"17","author":"P Shah","year":"2024","unstructured":"Shah P, Agbor-Enoh S, Lee S et al (2024) Racial differences in donor-derived cell-free DNA and mitochondrial DNA after heart transplantation, on behalf of the GRAfT investigators. Circ Heart Fail 17(4):e011160. https:\/\/doi.org\/10.1161\/circheartfailure.123.011160","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10443_CR23","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/j.healun.2016.01.449","volume":"35","author":"S Agbor-Enoh","year":"2016","unstructured":"Agbor-Enoh S, Fideli U, Doveikis J et al (2016) Genomic Research Alliance for Transplantation (GRAfT): a model for long term transplant studies in thoracic organ transplantation. J Heart Lung Transplant 35(4):S161. https:\/\/doi.org\/10.1016\/j.healun.2016.01.449","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10443_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","volume":"48","author":"NB Tsui","year":"2002","unstructured":"Tsui NB, Ng EK, Lo YM (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48(10):1647\u20131653","journal-title":"Clin Chem"},{"issue":"3","key":"10443_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1373\/clinchem.2003.028506","volume":"50","author":"T El-Hefnawy","year":"2004","unstructured":"El-Hefnawy T, Raja S, Kelly L et al (2004) Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 50(3):564\u2013573. https:\/\/doi.org\/10.1373\/clinchem.2003.028506","journal-title":"Clin Chem"},{"issue":"2","key":"10443_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/circresaha.116.308434","volume":"120","author":"J Viereck","year":"2017","unstructured":"Viereck J, Thum T (2017) Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res 120(2):381\u2013399. https:\/\/doi.org\/10.1161\/circresaha.116.308434","journal-title":"Circ Res"},{"issue":"1","key":"10443_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/17530059.2012.718329","volume":"7","author":"JE McDermott","year":"2013","unstructured":"McDermott JE, Wang J, Mitchell H et al (2013) Challenges in biomarker discovery: combining expert insights with statistical analysis of complex omics data. Expert Opin Med Diagn 7(1):37\u201351. https:\/\/doi.org\/10.1517\/17530059.2012.718329","journal-title":"Expert Opin Med Diagn"},{"issue":"3","key":"10443_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3978\/j.issn.2218-676X.2015.06.04","volume":"4","author":"N Goossens","year":"2015","unstructured":"Goossens N, Nakagawa S, Sun X et al (2015) Cancer biomarker discovery and validation. Transl Cancer Res 4(3):256\u2013269. https:\/\/doi.org\/10.3978\/j.issn.2218-676X.2015.06.04","journal-title":"Transl Cancer Res"},{"key":"10443_CR29","doi-asserted-by":"publisher","unstructured":"Ward Z, Schmeier S, Pearson J et al. (2022) Identifying candidate circulating RNA markers for coronary artery disease by deep RNA-sequencing in human plasma. Cells 11(20). https:\/\/doi.org\/10.3390\/cells11203191","DOI":"10.3390\/cells11203191"},{"issue":"10","key":"10443_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/circresaha.114.303915","volume":"114","author":"R Kumarswamy","year":"2014","unstructured":"Kumarswamy R, Bauters C, Volkmann I et al (2014) Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 114(10):1569\u20131575. https:\/\/doi.org\/10.1161\/circresaha.114.303915","journal-title":"Circ Res"},{"issue":"1","key":"10443_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-023-04820-1","volume":"22","author":"A Turkieh","year":"2024","unstructured":"Turkieh A, Beseme O, Saura O et al (2024) LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction. J Transl Med 22(1):31. https:\/\/doi.org\/10.1186\/s12967-023-04820-1","journal-title":"J Transl Med"},{"key":"10443_CR32","doi-asserted-by":"publisher","unstructured":"Sun Y, Jiang X, Lv Y et al. (2020) Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity. Biomolecules 10(2). https:\/\/doi.org\/10.3390\/biom10020187","DOI":"10.3390\/biom10020187"},{"issue":"1","key":"10443_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan MicroRNAs. Cell 173(1):20\u201351. https:\/\/doi.org\/10.1016\/j.cell.2018.03.006","journal-title":"Cell"},{"issue":"11","key":"10443_CR34","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jacc.2018.11.060","volume":"73","author":"LL Wong","year":"2019","unstructured":"Wong LL, Zou R, Zhou L et al (2019) Combining circulating microRNA and NT-proBNP to detect and categorize heart failure subtypes. J Am Coll Cardiol 73(11):1300\u20131313. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.060","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10443_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ejhf.223","volume":"17","author":"LL Wong","year":"2015","unstructured":"Wong LL, Armugam A, Sepramaniam S et al (2015) Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 17(4):393\u2013404. https:\/\/doi.org\/10.1002\/ejhf.223","journal-title":"Eur J Heart Fail"},{"key":"10443_CR36","doi-asserted-by":"publisher","unstructured":"Yan Y, Song D, Zhang X et al. (2020) GEO data sets analysis identifies COX-2 and its related micro RNAs as biomarkers for non-ischemic heart failure. Front Pharmacol 11(1155). https:\/\/doi.org\/10.3389\/fphar.2020.01155","DOI":"10.3389\/fphar.2020.01155"},{"issue":"1","key":"10443_CR37","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s12967-023-04558-w","volume":"21","author":"D de Gonzalo-Calvo","year":"2023","unstructured":"de Gonzalo-Calvo D, Martinez-Camblor P, Belmonte T et al (2023) Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach. J Transl Med 21(1):742. https:\/\/doi.org\/10.1186\/s12967-023-04558-w","journal-title":"J Transl Med"},{"issue":"2","key":"10443_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/circresaha.115.303567","volume":"115","author":"T Heidt","year":"2014","unstructured":"Heidt T, Courties G, Dutta P et al (2014) Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res 115(2):284\u2013295. https:\/\/doi.org\/10.1161\/circresaha.115.303567","journal-title":"Circ Res"},{"issue":"8","key":"10443_CR39","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai G, Schneider C, Wong N et al (2018) The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med 24(8):1234\u20131245. https:\/\/doi.org\/10.1038\/s41591-018-0059-x","journal-title":"Nat Med"},{"issue":"11","key":"10443_CR40","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/cvr\/cvad069","volume":"119","author":"AV Ruder","year":"2023","unstructured":"Ruder AV, Wetzels SMW, Temmerman L et al (2023) Monocyte heterogeneity in cardiovascular disease. Cardiovasc Res 119(11):2033\u20132045. https:\/\/doi.org\/10.1093\/cvr\/cvad069","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10443_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12920-021-00890-6","volume":"14","author":"Q Chen","year":"2021","unstructured":"Chen Q, Yin Q, Song J et al (2021) Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction. BMC Med Genomics 14(1):44. https:\/\/doi.org\/10.1186\/s12920-021-00890-6","journal-title":"BMC Med Genomics"},{"key":"10443_CR42","doi-asserted-by":"publisher","unstructured":"Chen Q, Su L, Liu C et al. (2022) PRKAR1A and SDCBP serve as potential predictors of heart failure following acute myocardial infarction. Front Immunol 13(878876). https:\/\/doi.org\/10.3389\/fimmu.2022.878876","DOI":"10.3389\/fimmu.2022.878876"},{"issue":"1","key":"10443_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13073-015-0149-z","volume":"7","author":"A Maciejak","year":"2015","unstructured":"Maciejak A, Kiliszek M, Michalak M et al (2015) Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure. Genome Med 7(1):26. https:\/\/doi.org\/10.1186\/s13073-015-0149-z","journal-title":"Genome Med"},{"key":"10443_CR44","doi-asserted-by":"publisher","unstructured":"Gupta M K, Halley C, Duan Z H et al. (2013) miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. J Mol Cell Cardiol 62(131\u2013141). https:\/\/doi.org\/10.1016\/j.yjmcc.2013.05.011","DOI":"10.1016\/j.yjmcc.2013.05.011"},{"issue":"3","key":"10443_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ehf2.12136","volume":"4","author":"M Toma","year":"2017","unstructured":"Toma M, Mak GJ, Chen V et al (2017) Differentiating heart failure phenotypes using sex-specific transcriptomic and proteomic biomarker panels. ESC Heart Fail 4(3):301\u2013311. https:\/\/doi.org\/10.1002\/ehf2.12136","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10443_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.healun.2023.09.009","volume":"43","author":"DH Lee","year":"2024","unstructured":"Lee DH, Usmani A, Ravichandran V et al (2024) Relationship between blood and tissue-based rejection-related transcripts in heart transplantation. J Heart Lung Transplant 43(3):359\u2013368. https:\/\/doi.org\/10.1016\/j.healun.2023.09.009","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"10443_CR47","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.healun.2019.05.008","volume":"38","author":"Y Moayedi","year":"2019","unstructured":"Moayedi Y, Fan CS, Miller RJH et al (2019) Gene expression profiling and racial disparities in outcomes after heart transplantation. J Heart Lung Transplant 38(8):820\u2013829. https:\/\/doi.org\/10.1016\/j.healun.2019.05.008","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10443_CR48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","volume":"6","author":"MC Deng","year":"2006","unstructured":"Deng MC, Eisen HJ, Mehra MR et al (2006) Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6(1):150\u2013160. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01175.x","journal-title":"Am J Transplant"},{"issue":"19","key":"10443_CR49","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1161\/01.cir.97.19.1921","volume":"97","author":"AM Richards","year":"1998","unstructured":"Richards AM, Nicholls MG, Yandle TG et al (1998) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97(19):1921\u20131929. https:\/\/doi.org\/10.1161\/01.cir.97.19.1921","journal-title":"Circulation"},{"issue":"4","key":"10443_CR50","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/01.cir.86.4.1081","volume":"86","author":"KJ Koller","year":"1992","unstructured":"Koller KJ, Goeddel DV (1992) Molecular biology of the natriuretic peptides and their receptors. Circulation 86(4):1081\u20131088. https:\/\/doi.org\/10.1161\/01.cir.86.4.1081","journal-title":"Circulation"},{"issue":"3","key":"10443_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161\u2013167. https:\/\/doi.org\/10.1056\/NEJMoa020233","journal-title":"N Engl J Med"},{"issue":"8895","key":"10443_CR52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/s0140-6736(94)92690-5","volume":"343","author":"M Davis","year":"1994","unstructured":"Davis M, Espiner E, Richards G et al (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343(8895):440\u2013444. https:\/\/doi.org\/10.1016\/s0140-6736(94)92690-5","journal-title":"Lancet"},{"issue":"1","key":"10443_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-024-03249-7","volume":"22","author":"KO Kuku","year":"2024","unstructured":"Kuku KO, Oyetoro R, Hashemian M et al (2024) Proteomics for heart failure risk stratification: a systematic review. BMC Med 22(1):34. https:\/\/doi.org\/10.1186\/s12916-024-03249-7","journal-title":"BMC Med"},{"issue":"1","key":"10443_CR54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41467-023-44680-3","volume":"15","author":"AM Shah","year":"2024","unstructured":"Shah AM, Myhre PL, Arthur V et al (2024) Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development. Nat Commun 15(1):528. https:\/\/doi.org\/10.1038\/s41467-023-44680-3","journal-title":"Nat Commun"},{"issue":"1","key":"10443_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM (2021) Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 22(1):19\u201337. https:\/\/doi.org\/10.1038\/s41576-020-0268-2","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10443_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/acs.chemrev.8b00257","volume":"119","author":"L Cohen","year":"2019","unstructured":"Cohen L, Walt DR (2019) Highly sensitive and multiplexed protein measurements. Chem Rev 119(1):293\u2013321. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00257","journal-title":"Chem Rev"},{"issue":"1","key":"10443_CR57","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1038\/s41467-019-13306-y","volume":"10","author":"A Egerstedt","year":"2019","unstructured":"Egerstedt A, Berntsson J, Smith ML et al (2019) Profiling of the plasma proteome across different stages of human heart failure. Nat Commun 10(1):5830. https:\/\/doi.org\/10.1038\/s41467-019-13306-y","journal-title":"Nat Commun"},{"issue":"7982","key":"10443_CR58","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH et al (2023) Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622(7982):348\u2013358. https:\/\/doi.org\/10.1038\/s41586-023-06563-x","journal-title":"Nature"},{"key":"10443_CR59","doi-asserted-by":"publisher","unstructured":"Brioschi M, Gianazza E, Agostoni P et al. (2021) Multiplexed MRM-based proteomics identified multiple biomarkers of disease severity in human heart failure. Int J Mol Sci 22(2). https:\/\/doi.org\/10.3390\/ijms22020838","DOI":"10.3390\/ijms22020838"},{"issue":"5","key":"10443_CR60","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ejhf.65","volume":"16","author":"Z Hollander","year":"2014","unstructured":"Hollander Z, Laz\u00e1rov\u00e1 M, Lam KK et al (2014) Proteomic biomarkers of recovered heart function. Eur J Heart Fail 16(5):551\u2013559. https:\/\/doi.org\/10.1002\/ejhf.65","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10443_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ejhf.1608","volume":"22","author":"TH Cao","year":"2020","unstructured":"Cao TH, Jones DJL, Voors AA et al (2020) Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets. Eur J Heart Fail 22(1):70\u201380. https:\/\/doi.org\/10.1002\/ejhf.1608","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10443_CR62","doi-asserted-by":"publisher","first-page":"e006749","DOI":"10.1161\/circheartfailure.119.006749","volume":"13","author":"M Nayor","year":"2020","unstructured":"Nayor M, Short MI, Rasheed H et al (2020) Aptamer-based proteomic platform identifies novel protein predictors of incident heart failure and echocardiographic traits. Circ Heart Fail 13(5):e006749. https:\/\/doi.org\/10.1161\/circheartfailure.119.006749","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10443_CR63","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/circulationaha.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho CY, Day SM, Ashley EA et al (2018) Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 138(14):1387\u20131398. https:\/\/doi.org\/10.1161\/circulationaha.117.033200","journal-title":"Circulation"},{"issue":"24","key":"10443_CR64","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1136\/heartjnl-2023-322644","volume":"109","author":"HS Lumish","year":"2023","unstructured":"Lumish HS, Liang LW, Hasegawa K et al (2023) Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics. Heart 109(24):1837\u20131843. https:\/\/doi.org\/10.1136\/heartjnl-2023-322644","journal-title":"Heart"},{"issue":"22","key":"10443_CR65","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1136\/heartjnl-2021-320729","volume":"108","author":"LW Liang","year":"2022","unstructured":"Liang LW, Raita Y, Hasegawa K et al (2022) Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy. Heart 108(22):1807\u20131814. https:\/\/doi.org\/10.1136\/heartjnl-2021-320729","journal-title":"Heart"},{"issue":"1","key":"10443_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-019-1010-z","volume":"14","author":"H Chen","year":"2019","unstructured":"Chen H, Li X, Liu X et al (2019) Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort. Orphanet J Rare Dis 14(1):29. https:\/\/doi.org\/10.1186\/s13023-019-1010-z","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10443_CR67","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","volume":"106","author":"\u00c5K Hedman","year":"2020","unstructured":"Hedman \u00c5K, Hage C, Sharma A et al (2020) Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart 106(5):342\u2013349. https:\/\/doi.org\/10.1136\/heartjnl-2019-315481","journal-title":"Heart"},{"issue":"2","key":"10443_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacbts.2020.11.011","volume":"6","author":"TC Hanff","year":"2021","unstructured":"Hanff TC, Cohen JB, Zhao L et al (2021) Quantitative proteomic analysis of diabetes mellitus in heart failure with preserved ejection fraction. JACC Basic Transl Sci 6(2):89\u201399. https:\/\/doi.org\/10.1016\/j.jacbts.2020.11.011","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10443_CR69","doi-asserted-by":"publisher","first-page":"e003191","DOI":"10.1161\/circgen.120.003191","volume":"14","author":"DH Katz","year":"2021","unstructured":"Katz DH, Tahir UA, Ngo D et al (2021) Multiomic profiling in Black and White populations reveals novel candidate pathways in left ventricular hypertrophy and incident heart failure specific to black adults. Circ Genom Precis Med 14(3):e003191. https:\/\/doi.org\/10.1161\/circgen.120.003191","journal-title":"Circ Genom Precis Med"},{"issue":"15","key":"10443_CR70","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1161\/circulationaha.119.045158","volume":"142","author":"MY Chan","year":"2020","unstructured":"Chan MY, Efthymios M, Tan SH et al (2020) Prioritizing candidates of post-myocardial infarction heart failure using plasma proteomics and single-cell transcriptomics. Circulation 142(15):1408\u20131421. https:\/\/doi.org\/10.1161\/circulationaha.119.045158","journal-title":"Circulation"},{"issue":"7","key":"10443_CR71","doi-asserted-by":"publisher","first-page":"e010255","DOI":"10.1161\/circheartfailure.122.010255","volume":"16","author":"AM van Ommen","year":"2023","unstructured":"van Ommen AM, Diez Benavente E, Onland-Moret NC et al (2023) Plasma proteomic patterns show sex differences in early concentric left ventricular remodeling. Circ Heart Fail 16(7):e010255. https:\/\/doi.org\/10.1161\/circheartfailure.122.010255","journal-title":"Circ Heart Fail"},{"issue":"23","key":"10443_CR72","doi-asserted-by":"publisher","first-page":"e023330","DOI":"10.1161\/jaha.121.023330","volume":"10","author":"L Lind","year":"2021","unstructured":"Lind L, Zanetti D, Ingelsson M et al (2021) Large-scale plasma protein profiling of incident myocardial infarction, ischemic stroke, and heart failure. J Am Heart Assoc 10(23):e023330. https:\/\/doi.org\/10.1161\/jaha.121.023330","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10443_CR73","doi-asserted-by":"publisher","first-page":"e009694","DOI":"10.1161\/circheartfailure.122.009694","volume":"16","author":"N Girerd","year":"2023","unstructured":"Girerd N, Levy D, Duarte K et al (2023) Protein biomarkers of new-onset heart failure: insights from the heart omics and ageing cohort, the atherosclerosis risk in communities study, and the Framingham Heart Study. Circ Heart Fail 16(5):e009694. https:\/\/doi.org\/10.1161\/circheartfailure.122.009694","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10443_CR74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ejhf.2435","volume":"24","author":"C Chandramouli","year":"2022","unstructured":"Chandramouli C, Ting TW, Tromp J et al (2022) Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction. Eur J Heart Fail 24(4):681\u2013684. https:\/\/doi.org\/10.1002\/ejhf.2435","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10443_CR75","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jchf.2022.05.013","volume":"10","author":"P Pandhi","year":"2022","unstructured":"Pandhi P, Ter Maaten JM, Anker SD et al (2022) Pathophysiologic processes and novel biomarkers associated with congestion in heart failure. JACC Heart Fail 10(9):623\u2013632. https:\/\/doi.org\/10.1016\/j.jchf.2022.05.013","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10443_CR76","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ejhf.2144","volume":"23","author":"RJ Woolley","year":"2021","unstructured":"Woolley RJ, Ceelen D, Ouwerkerk W et al (2021) Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail 23(6):983\u2013991. https:\/\/doi.org\/10.1002\/ejhf.2144","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10443_CR77","doi-asserted-by":"publisher","first-page":"e003140","DOI":"10.1161\/circgen.120.003140","volume":"14","author":"H Gui","year":"2021","unstructured":"Gui H, She R, Luzum J et al (2021) Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction. Circ Genom Precis Med 14(3):e003140. https:\/\/doi.org\/10.1161\/circgen.120.003140","journal-title":"Circ Genom Precis Med"},{"issue":"11","key":"10443_CR78","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.cir.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack MN, Rader TA, Park S et al (1996) Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94(11):2837\u20132842. https:\/\/doi.org\/10.1161\/01.cir.94.11.2837","journal-title":"Circulation"},{"issue":"22","key":"10443_CR79","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/circulationaha.119.045033","volume":"141","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj S, Kelly DP, Margulies KB (2020) Implications of altered ketone metabolism and therapeutic ketosis in heart failure. Circulation 141(22):1800\u20131812. https:\/\/doi.org\/10.1161\/circulationaha.119.045033","journal-title":"Circulation"},{"issue":"13","key":"10443_CR80","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2014.04.083","volume":"64","author":"W Doehner","year":"2014","unstructured":"Doehner W, Frenneaux M, Anker SD (2014) Metabolic impairment in heart failure: the myocardial and systemic perspective. J Am Coll Cardiol 64(13):1388\u20131400. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.083","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10443_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-022-01652-z","volume":"21","author":"C Puig-Jov\u00e9","year":"2022","unstructured":"Puig-Jov\u00e9 C, Julve J, Castelblanco E et al (2022) The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovasc Diabetol 21(1):257. https:\/\/doi.org\/10.1186\/s12933-022-01652-z","journal-title":"Cardiovasc Diabetol"},{"key":"10443_CR82","doi-asserted-by":"publisher","unstructured":"Jianjun Wu Y Z, . L J and et al. (2023) Associations among microvascular dysfunction, fatty acid metabolism, and diabetes. Cardiovasc Innov Appl 8(1). https:\/\/doi.org\/10.15212\/cvia.2023.0076","DOI":"10.15212\/cvia.2023.0076"},{"issue":"9","key":"10443_CR83","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11427-019-9548-9","volume":"62","author":"X Zhang","year":"2019","unstructured":"Zhang X, Liu H, Gao J et al (2019) Metabolic disorder in the progression of heart failure. Sci China Life Sci 62(9):1153\u20131167. https:\/\/doi.org\/10.1007\/s11427-019-9548-9","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10443_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1373\/clinchem.2016.257279","volume":"63","author":"M Mueller-Hennessen","year":"2017","unstructured":"Mueller-Hennessen M, D\u00fcngen HD, Lutz M et al (2017) A novel lipid biomarker panel for the detection of heart failure with reduced ejection fraction. Clin Chem 63(1):267\u2013277. https:\/\/doi.org\/10.1373\/clinchem.2016.257279","journal-title":"Clin Chem"},{"issue":"6","key":"10443_CR85","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cardfail.2015.04.005","volume":"21","author":"E Nemutlu","year":"2015","unstructured":"Nemutlu E, Zhang S, Xu YZ et al (2015) Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure. J Card Fail 21(6):460\u2013469. https:\/\/doi.org\/10.1016\/j.cardfail.2015.04.005","journal-title":"J Card Fail"},{"issue":"7","key":"10443_CR86","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jchf.2017.02.016","volume":"5","author":"RC Starling","year":"2017","unstructured":"Starling RC, Estep JD, Horstmanshof DA et al (2017) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP Study 2-year results. JACC Heart Fail 5(7):518\u2013527. https:\/\/doi.org\/10.1016\/j.jchf.2017.02.016","journal-title":"JACC Heart Fail"},{"key":"10443_CR87","doi-asserted-by":"publisher","unstructured":"Topkara V K, Garan A R, Fine B et al. (2016) Myocardial recovery in patients receiving contemporary left ventricular assist devices: results from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Circ Heart Fail 9(7). https:\/\/doi.org\/10.1161\/circheartfailure.116.003157","DOI":"10.1161\/circheartfailure.116.003157"},{"issue":"16","key":"10443_CR88","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jacc.2016.07.756","volume":"68","author":"J Wever-Pinzon","year":"2016","unstructured":"Wever-Pinzon J, Selzman CH, Stoddard G et al (2016) Impact of ischemic heart failure etiology on cardiac recovery during mechanical unloading. J Am Coll Cardiol 68(16):1741\u20131752. https:\/\/doi.org\/10.1016\/j.jacc.2016.07.756","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10443_CR89","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ejhf.116","volume":"16","author":"AC Morley-Smith","year":"2014","unstructured":"Morley-Smith AC, Mills A, Jacobs S et al (2014) Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail 16(8):871\u2013879. https:\/\/doi.org\/10.1002\/ejhf.116","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10443_CR90","doi-asserted-by":"publisher","first-page":"240","DOI":"10.21037\/acs-2020-cfmcs-117","volume":"10","author":"F Consolo","year":"2021","unstructured":"Consolo F, Barberini L, Fattuoni C et al (2021) Metabolomic profile of patients with left ventricular assist devices: a pilot study. Ann Cardiothorac Surg 10(2):240\u2013247. https:\/\/doi.org\/10.21037\/acs-2020-cfmcs-117","journal-title":"Ann Cardiothorac Surg"},{"key":"10443_CR91","doi-asserted-by":"publisher","unstructured":"Xu M, Cui H, Chen X et al. (2022) Changes of plasma tris(hydroxymethyl)aminomethane and 5-guanidino-3-methyl-2-oxopentanoic acid as biomarkers of heart remodeling after left ventricular assist device support. Metabolites 12(11). https:\/\/doi.org\/10.3390\/metabo12111068","DOI":"10.3390\/metabo12111068"},{"issue":"1","key":"10443_CR92","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/cvr\/cvad162","volume":"120","author":"MB Nielsen","year":"2024","unstructured":"Nielsen MB, \u00c7olak Y, Benn M et al (2024) Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence. Cardiovasc Res 120(1):95\u2013107. https:\/\/doi.org\/10.1093\/cvr\/cvad162","journal-title":"Cardiovasc Res"},{"issue":"16","key":"10443_CR93","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/circulationaha.121.056663","volume":"145","author":"A Henry","year":"2022","unstructured":"Henry A, Gordillo-Mara\u00f1\u00f3n M, Finan C et al (2022) Therapeutic targets for heart failure identified using proteomics and mendelian randomization. Circulation 145(16):1205\u20131217. https:\/\/doi.org\/10.1161\/circulationaha.121.056663","journal-title":"Circulation"},{"issue":"5","key":"10443_CR94","doi-asserted-by":"publisher","first-page":"e031154","DOI":"10.1161\/jaha.123.031154","volume":"13","author":"MJ Dib","year":"2024","unstructured":"Dib MJ, Levin MG, Zhao L et al (2024) Proteomic associations of adverse outcomes in human heart failure. J Am Heart Assoc 13(5):e031154. https:\/\/doi.org\/10.1161\/jaha.123.031154","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10443_CR95","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1038\/s41467-022-34216-6","volume":"13","author":"MG Levin","year":"2022","unstructured":"Levin MG, Tsao NL, Singhal P et al (2022) Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun 13(1):6914. https:\/\/doi.org\/10.1038\/s41467-022-34216-6","journal-title":"Nat Commun"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10443-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T02:08:48Z","timestamp":1734142128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10443-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["10443"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10443-5","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"25 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}